# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Susquehanna analyst James Friedman maintains MercadoLibre (NASDAQ:MELI) with a Positive and lowers the price target from $29...
https://www.bloomberg.com/news/articles/2025-10-09/mercadolibre-works-with-brazil-regulators-in-a-push-for-pharma
Citigroup analyst Joao Pedro Soares maintains MercadoLibre (NASDAQ:MELI) with a Buy and lowers the price target from $2850 t...
- Reuters